In CTCL, the early infiltrating CD4 T cells display a TH1 phenotype and in concert, these immune cells are seemingly capable of controlling CTCL cell expansion via cytokines and cytotoxicity [25,26,27,28]. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.